City University of New York
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, City University of New York sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
City University of New York: 9 sponsored US clinical trials, 1 recruiting.
City University of New York sponsors 9 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Lactation Disorder - Postpartum Condition or Complication, with 1 trials.
Top-decile sponsor footprint
City University of New York ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
9 total, page 1 of 1
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
NCT04142866
Use of Ritual Epost Postnatal Multivitamins During the Postpartum Period
NCT05736562
Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program
NCT05140421
Nutrition Intervention Combined With Resmetirom for MASH
NCT07680478
Use of Ritual Prenatal Multivitamins for Pregnancy
NCT05673070
Assessing Perceptions and Preferences Around Long-acting Injectables (APPLI)
NCT05833542
Transspinal Stimulation Plus Locomotor Training for SCI
NCT04807764
Activity-Dependent Transspinal Stimulation in SCI
NCT03669302
Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border
NCT03293875
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
Where City University of New York enrollment is open (later-stage tilt)
1 recruiting of 9 indexed (11% open); 4 completed (44%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Lactation Disorder - Postpartum Condition or Complication (1 trial), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
City University of New York: open-pipeline peers nationwide
Peers matched on 9 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
City University of New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 trials (± recruiting share)
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors near 11% open enrollment (± trial volume)
- ADC Therapeutics S.A. · 11% recruiting · 18 trials
- Adrian Vella · 11% recruiting · 9 trials
- AIDS Malignancy Consortium · 11% recruiting · 45 trials
- Amylyx Pharmaceuticals · 11% recruiting · 9 trials
Related
What to do with this City University of New York page
9 registered trials is a research-attention snapshot, not an endorsement of City University of New York or any single study.
- 1 of City University of New York's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Lactation Disorder - Postpartum Condition or Complication is the condition City University of New York studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Lactation Disorder - Postpartum Condition or Complication trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
City University of New York pipeline card: 9 registered trials from official public datasets.Report a data error.